SPA Securities neutral on Birla Cotsyn IPO
Published on Wed, Jul 02, 2008 at 09:23 , Updated at Wed, Jul 02, 2008 at 09:27
Source : moneycontrol.com
| ads by google |
SPA Securities has come out with a research report on Birla Cotsyn (India) IPO. It has recommended a neutral rating on the issue. Birla Cotsyn (India) has opened for subscription with its initial public offering (IPO) of Rs 1441.8 million. The issue will close on July 4, 2008. The price band is between Rs 15 to Rs 18 per equity share. SPA's report on Birla Cotsyn (India) IPO: Investment Positives: The expansion project has been awarded the “Mega Project” status by Maharashtra government which will result in tax benefits, electricity duty exemption, Industrial promotion subsidy equivalent to 100% of the eligible investments made etc. The company is planning to be a fully integrated textile company with its scope of operations ranging from ginning, to spinning to fabrics, readymade garments and further owning its own retail shops. Investment Concerns: Birla Cotsyn is looking at aggressive expansion plan and is aiming at becoming integrated textile company. Textile sector is currently out of favor due to unfavorable business conditions such as rising cotton prices, yarn realizations under pressure due to tough competition, huge competition from china and other exporters in export market coupled with risk of forex fluctuations. As the company is funding its plans through this IPO, it will put a lot of strain on its balance sheet as the post issue equity base is going to 7x of pre-issue. Valuation: The stock is available at a P/E of 50x on its upper band of Rs 18, which is the highest in the peer group. The margins recorded by BCL at EBITDA and PAT level are also on the lower side when compared with its peers. The risk of executing such large projects is high. The rise in cotton prices might impact the margins of the company. Since BCL intends to export 50% of their production (currently it exports ~25%) it will be exposed to forex fluctuations. Promoter & PAC stake post dilution will be below 30%. BCL intends to market its products to the premium and middle segment of the consumers. The promoters have extensive experience in this industry. We expect that BCL‟s retail operations will help in improving the margins. Investors with long term prospective can invest in this issue. Hence, we recommend "Neutral" to the issue. Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions. |
Attachments : Birla_Cotsyn_IPO_Note_SPA_Neutral.pdf |
Messages on IPO, New Issues
Other comments
Chemcel Biotech to list on Oct 13
Chemcel Biotech a company engaged in the business of agro-chemicals will list on the bourses with its equity shares...
in IPO, New Issues - MMB Messenger at 10-Oct-08 12:40
The Govt should motivate the market by slowly and time the nationalisation of some govt undertakings at good price ...
in IPO, New Issues - asana at 10-Oct-08 12:36
Rate this article
News
10-10 Alkali Metals extends its IPO till October 15
10-10 CRISIL reaffirms IPO grade 3/5 to Mandhana Industries IPO
Expert Advice
06-10 20 Microns fully priced at issue price
04-09 Austral Coke's fair value at discount to IPO price
Red Herring Document
| Company | Date |
| KSK Energy Ventures | 14-Feb-2008 |
| Lotus Eye Care Hospital | 01-Feb-2008 |
| Nu Tek India | 16-Jan-2008 |
| Bafna Pharmaceuticals | 27-Dec-2007 |
| Birla Cotsyn (India) | 27-Dec-2007 |
Chat
Ambareesh Baliga
, Karvy Stock Broking
(13 Oct- 16:00hrs)
What's the outlook for the market?
Poll
Newsletter
Keep in touch with News day & night. Subscribe to:
Mobile Services
Get news on the move SMS to 52622
- SMS M for Market News
- SMS B for Latest Business News
- SMS S (stock name) for latest news




Offline



